Lexicon Pharmaceuticals Balance Sheet
NASDAQ: LXRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lexicon Pharmaceuticals financial position
At the end of fiscal 2025, Lexicon Pharmaceuticals reported total assets of $185.0 million, down 38.0% from a year earlier against total liabilities of $77.4 million. Shareholders' equity stood at $107.5 million, or 58.1% of assets. The company held $34.3 million in cash and equivalents against $54.0 million of debt, a net debt position of $19.7 million.
The current ratio (current assets divided by current liabilities) was 4.88, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.50.
Summary generated from market data by MetaCap's automated system. Methodology
Lexicon Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20192020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 34.33M | 66.66M | 22.46M | 46.34M | 64.06M | 126.26M | 36.11M | 80.39M | 61.66M | 46.60M |
| Short-Term Investments | 61.90M | 171.30M | 147.56M | 92.01M | 22.68M | 26.01M | 235.55M | 79.67M | 249.13M | 299.90M |
| Receivables | 2.38M | 3.47M | 1.01M | 28.00K | 14.00K | 395.00K | 56.53M | 5.92M | 4.83M | 7.49M |
| Inventory | 281.00K | 231.00K | 381.00K | 0 | — | 0 | 4.24M | 4.68M | 1.95M | 0 |
| Total Current Assets | 101.89M | 246.19M | 176.55M | 140.87M | 88.92M | 157.72M | 337.75M | 173.32M | 322.00M | 357.87M |
| Property, Plant & Equipment | 1.86M | 2.48M | 1.99M | 2.07M | 1.18M | 295.00K | 14.05M | 15.87M | 17.69M | 19.39M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Intangible Assets | — | — | — | — | — | — | 19.72M | 50.12M | 51.88M | 53.36M |
| Total Assets | 184.99M | 298.42M | 229.43M | 194.30M | 136.91M | 203.79M | 417.71M | 284.14M | 436.54M | 475.63M |
| Accounts Payable | 3.08M | 14.80M | 14.39M | 10.39M | 9.15M | 5.47M | 12.18M | 12.05M | 38.76M | 52.88M |
| Short-Term Debt | 4.59M | 0 | — | — | 0 | 11.65M | 11.01M | 1.11M | 14.09M | 16.28M |
| Total Current Liabilities | 20.87M | 45.25M | 31.55M | 23.17M | 22.12M | 46.81M | 65.34M | 36.75M | 105.49M | 164.64M |
| Long-Term Debt | 49.41M | 100.30M | 99.51M | 48.58M | 0 | 0 | 234.17M | 243.89M | 231.58M | 85.17M |
| Total Liabilities | 77.45M | 152.47M | 136.32M | 77.17M | 23.31M | 47.42M | 300.61M | 310.54M | 368.27M | 318.22M |
| Shareholders' Equity | 107.54M | 145.95M | 93.11M | 117.12M | 113.59M | 156.37M | 117.10M | -26.41M | 68.27M | 167.51M |
| Retained Earnings | -2.02B | -1.97B | -1.77B | -1.59B | -1.49B | -1.40B | -1.34B | -1.47B | -1.37B | -1.25B |
| Total Debt | 54.00M | 100.30M | 99.51M | 48.58M | 0 | 11.65M | 245.18M | 245.00M | 245.67M | 101.45M |
| Net Cash (Debt) | 42.23M | 137.66M | 70.52M | 89.78M | 86.74M | 140.63M | 26.48M | -84.95M | 65.12M | 245.06M |
| Shares Outstanding | 365.85M | 363.02M | — | — | — | — | — | — | — | — |
This table shows 10 annual periods of Lexicon Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow LXRX's reporting calendar. What is a balance sheet?